Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study Bob T Li , Funda Meric-Bernstam , Aditya Bardia , Yoichi Naito , Salvatore Siena , Philippe Aftimos , Ian Anderson , Giuseppe Curigliano , Maria de Miguel , Maitri Kalra , Do-Youn Oh , Joon Oh Park , Sophie Postel-Vinay , Sun Young Rha , Taroh Satoh , Iben Spanggaard , Flavia Michelini , Ann Smith , Karime Kalil Machado , Cristina Saura , Bob T Li , Funda Meric-Bernstam , Aditya Bardia , Yoichi Naito , Salvatore Siena , Philippe Aftimos , Ian Anderson , Giuseppe Curigliano , Maria de Miguel , Maitri Kalra , Do-Youn Oh , Joon Oh Park , Sophie Postel-Vinay , Sun Young Rha , Taroh Satoh , Iben Spanggaard , Flavia Michelini , Ann Smith , Karime Kalil Machado , Cristina Saura The Lancet Oncology（2024）
AI 理解论文
溯源树
样例
